{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:56:54Z","timestamp":1787021814226,"version":"build-2736575974"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003881","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T13:48:44Z","timestamp":1436363324000},"page":"e0003881","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Md. Abu","family":"Sayeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan Kelly","family":"Bufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Eckhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richelle C.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Murshid","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rasheduzzaman","family":"Rashu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Gonzalez-Escobedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Mandlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taufiqur Rahman","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina C.","family":"LaRocque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Calderwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. F.","family":"Vann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"Kov\u00e1\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera","volume":"379","author":"JB Harris","year":"2012","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/IDR.S10339","article-title":"Review of oral cholera vaccines: efficacy in young children","volume":"4","author":"C Masuet Aumatell","year":"2011","journal-title":"Infect Drug Resist"},{"key":"ref3","first-page":"117","article-title":"Cholera vaccines: WHO position paper","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/eri.12.23","article-title":"Immune responses to cholera in children","volume":"10","author":"DT Leung","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1371\/journal.pntd.0000173","article-title":"The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa","volume":"2","author":"JL Deen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","article-title":"Cholera","volume":"363","author":"DA Sack","year":"2004","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/MMBR.62.4.1301-1314.1998","article-title":"Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae","volume":"62","author":"SM Faruque","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.4.2.5122","article-title":"Cholera vaccines for the developing world","volume":"4","author":"AL Lopez","year":"2008","journal-title":"Hum Vaccin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/infdis\/169.1.230","article-title":"Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR","volume":"169","author":"MJ Albert","year":"1994","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/IAI.65.9.3571-3576.1997","article-title":"Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1","volume":"65","author":"F Qadri","year":"1997","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1073\/pnas.91.24.11388","article-title":"The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants","volume":"91","author":"MK Waldor","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/bbrc.1993.1046","article-title":"Occurrence of 2-O-methyl-N-(3-deoxy-L-glycero-tetronyl)-D-perosamine (4-amino-4,6-dideoxy-D-manno-pyranose) in lipopolysaccharide from Ogawa but not from Inaba O forms of O1 Vibrio cholerae","volume":"190","author":"K Hisatsune","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"ref13","first-page":"343","article-title":"Period of excretion of Vibrio cholerae in convalescents","volume":"7","author":"CB Gilmour","year":"1952","journal-title":"Bull World Health Organ"},{"issue":"Suppl 121","key":"ref14","first-page":"121","article-title":"The 1968\u20131969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests","volume":"121","author":"WH Mosley","year":"1970","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(67)92542-1","article-title":"Multiple serotypes of vibrio cholerae isolated from a case of cholera. Evidence suggesting in-vivo mutation","volume":"1","author":"EJ Gangarosa","year":"1967","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e2683","DOI":"10.1371\/journal.pntd.0002683","article-title":"Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide","volume":"8","author":"MM Alam","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1128\/CVI.00321-12","article-title":"Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera","volume":"19","author":"RA Johnson","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/CVI.05689-11","article-title":"Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice","volume":"19","author":"AA Tarique","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1021\/bc2001984","article-title":"Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines","volume":"22","author":"P Xu","year":"2011","journal-title":"Bioconjug Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0008-6215(01)00018-0","article-title":"Conjugating oligosaccharides to proteins by squaric acid diester chemistry: rapid monitoring of the progress of conjugation, and recovery of the unused ligand","volume":"330","author":"A Chernyak","year":"2001","journal-title":"Carbohydr Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0021-9258(19)81445-X","article-title":"Removal of fatty acids from serum albumin by charcoal treatment","volume":"242","author":"RF Chen","year":"1967","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.polymer.2004.11.024","article-title":"Synthesis and characterization of alternating poly(amide urethane)s from \u03b5-caprolactone, diamines and diphenyl carbonate","volume":"46","author":"B Sharma","year":"2005","journal-title":"Polymer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1016\/j.vaccine.2009.06.040","article-title":"Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice","volume":"27","author":"JE Rollenhagen","year":"2009","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/IAI.68.2.977-981.2000","article-title":"Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains","volume":"68","author":"TI Crean","year":"2000","journal-title":"Infect Immun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1128\/IAI.64.10.4373-4377.1996","article-title":"Development of a germfree mouse model of Vibrio cholerae infection","volume":"64","author":"JR Butterton","year":"1996","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1128\/IAI.65.8.3118-3125.1997","article-title":"Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice","volume":"65","author":"ET Ryan","year":"1997","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.65.7.2941-2949.1997","article-title":"Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain","volume":"65","author":"ET Ryan","year":"1997","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-1759(96)00146-9","article-title":"Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay","volume":"199","author":"MK Slifka","year":"1996","journal-title":"J Immunol Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/IAI.01382-12","article-title":"Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen","volume":"81","author":"DR Leitner","year":"2013","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1128\/IAI.64.9.3778-3785.1996","article-title":"Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development","volume":"64","author":"G Jonson","year":"1996","journal-title":"Infect Immun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1995-7645(11)60149-1","article-title":"Cholera: a great global concern","volume":"4","author":"S Mandal","year":"2011","journal-title":"Asian Pac J Trop Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/cir141","article-title":"Oral vaccines against cholera","volume":"52","author":"S Shin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4269\/ajtmh.2008.79.708","article-title":"Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh","volume":"79","author":"AM Harris","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10719-013-9490-x","article-title":"Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates","volume":"30","author":"PC McCarthy","year":"2013","journal-title":"Glycoconj J"},{"key":"ref35","first-page":"CD000974","article-title":"Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)","author":"PM Graves","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00281-006-0054-z","article-title":"IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity","volume":"28","author":"M Yoshida","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2004.05.007","article-title":"Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells","volume":"20","author":"M Yoshida","year":"2004","journal-title":"Immunity"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI6968","article-title":"Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line","volume":"104","author":"BL Dickinson","year":"1999","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2567.1997.00326.x","article-title":"Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells","volume":"92","author":"EJ Israel","year":"1997","journal-title":"Immunology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(02)00345-6","article-title":"Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen","volume":"20","author":"JW Conlan","year":"2002","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.vaccine.2010.06.062","article-title":"Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults","volume":"28","author":"PE Laurent","year":"2010","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/chem.200500518","article-title":"Chemical and chemoenzymatic synthesis of S-linked ganglioside analogues and their protein conjugates for use as immunogens","volume":"12","author":"JR Rich","year":"2006","journal-title":"Chemistry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1021\/ol048614m","article-title":"A new homobifunctional p-nitro phenyl ester coupling reagent for the preparation of neoglycoproteins","volume":"6","author":"X Wu","year":"2004","journal-title":"Org Lett"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh","volume":"189","author":"D Saha","year":"2004","journal-title":"J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1128\/IAI.00369-09","article-title":"Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh","volume":"77","author":"AM Harris","year":"2009","journal-title":"Infect Immun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1371\/journal.pntd.0000221","article-title":"Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh","volume":"2","author":"JB Harris","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e96499","DOI":"10.1371\/journal.pone.0096499","article-title":"Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India","volume":"9","author":"S Kanungo","year":"2014","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1016\/j.vaccine.2009.09.008","article-title":"Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial","volume":"27","author":"S Kanungo","year":"2009","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","article-title":"Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial","volume":"5","author":"D Sur","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref50","first-page":"CD008603","article-title":"Oral vaccines for preventing cholera","author":"D Sinclair","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/CVI.00562-10","article-title":"Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera","volume":"18","author":"MM Alam","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"SK Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/CVI.00196-12","article-title":"Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera","volume":"19","author":"M Arifuzzaman","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/CVI.00037-12","article-title":"Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh","volume":"19","author":"SM Patel","year":"2012","journal-title":"Clin Vaccine Immunol"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T17:03:42Z","timestamp":1652807022000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003881"}},"subtitle":[],"editor":[{"given":"Pamela L. C.","family":"Small","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,8]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003881","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,8]]}}}